Caris Designates Fox Chase a Caris Center of Excellence in Precision Medicine

Wafik-El-Deiry-revCaris Life Sciences® has designated Fox Chase Cancer Center a center of excellence site in the Caris Centers of Excellence for Precision Medicine Network™. Wafik El-Deiry, MD, PhD, FACP, deputy cancer center director for translational research and co-program leader of Molecular Therapeutics, will join the Network Steering Committee to establish guidelines and research protocols for tumor profiling. Fox Chase will participate in the development of standards of care and best practices for integrating and utilizing molecular profiling in oncology practice while also striving to increase widespread adoption and patient access to precision medicine in clinical settings. Fox Chase will also leverage Caris’ multiple-technology tumor profiling service, Caris Molecular Intelligence®, to further the Institute’s practice of precision medicine by identifying therapy options and clinical trial opportunities based on the unique characteristics of a patient’s tumor.